This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Madersbacher, S. Articles by Marberger, M. Search for Related Content PubMed PubMed Citation Articles by Madersbacher, S. Articles by Marberger, M.

Effect of High-Intensity Focused Ultrasound on Human Prostate Cancer in Vivo

Departments of Urology [S. M., M. P., L. V., M. M.] and Pathology [M. S.], University of Vienna, Wahringer Gurtel 18–20, A-1090 Vienna, Austria

Transrectal high-intensity focused ultrasound (HIFU) was recently established as a highly effective means of inducing contact and irradiation-free intraprostatic coagulative necrosis. This technique, therefore, appears potentially useful for treating localized prostate cancer (PC). To evaluate this issue, a total of 29 human prostates with localized cancer was subjected to HIFU treatment in vivo before radical retropublic prostatectomy. HIFU therapy was performed with the use of HIFU transducers with focal lengths of 3.0 cm (n = 3), 3.5 cm (n = 19), and 4.0 cm (n = 7), and the site intensity was varied from 1260 to 2000 W/cm². The extent of intraprostatic necrosis was determined by planimetrical analysis of whole mount prostatic sections. Transrectal HIFU consistently induced sharply delineated intraprostatic coagulative necrosis within the target area, whereas alterations of periprostatic structures were never observed. The cross-sectional area of necrosis increased from 1.1 ± 0.7 cm² (SD; n = 3; 3.0-cm focal length; 1428 W/cm²) to 1.2 ± 0.7 cm² (n = 2; 3.5-cm focal length; 1428 W/cm²), 1.8 ± 0.17 cm² (n = 8; 3.5-cm focal length; 1680 W/cm²), 2.8 ± 0.32 cm² (n = 9; 3.5-cm focal length; 2000 W/cm²) and 3.8 ± 0.4 cm² (n = 7; 4.0 cm focal length; 1260 W/cm²). HIFU beam transmission and the therapeutic effect were comparable in benign and malignant prostatic tissue. Interstitial thermometry (n = 6) revealed maximum intraprostatic temperatures in the focal zone up to 98.6°C. Outside the focal zone and on the rectal wall, no significant temperature rises were noted. Subsequently, HIFU was applied to unilateral histologically proven T_2a/T_2b PC (n = 10) in an attempt to destroy all cancer before radical retropubic prostatectomy. PC was always correctly targeted. In 7 individuals, PC was partially (mean, 53%; range, 38–77%) destroyed; in the remaining 3 cases the entire tumor was ablated. Although these histological data permit no definitive conclusion on the clinical efficacy of this approach, transrectal HIFU seems to be a an attractive novel minimally invasive treatment option for localized PC.

¹ To whom requests for reprints should be addressed.

Received 1/11/95. Accepted 5/30/95.

This article has been cited by other articles:

				M. NONAKA, M. YAMAMOTO, S. YOSHINO, S.-I. UMEMURA, K. SASAKI, and T. FUKUSHIMA Sonodynamic Therapy Consisting of Focused Ultrasound and a Photosensitizer Causes a Selective Antitumor Effect in a Rat Intracranial Glioma Model Anticancer Res, March 1, 2009; 29(3): 943 - 950. [Abstract] [Full Text] [PDF]

				J.-B. Liu, G. Wansaicheong, D. A. Merton, S.-Y. Chiou, Y. Sun, K. Li, F. Forsberg, P. R. Edmonds, L. Needleman, and E. J. Halpern Canine Prostate: Contrast-enhanced US-guided Radiofrequency Ablation with Urethral and Neurovascular Cooling--Initial Experience Radiology, June 1, 2008; 247(3): 717 - 725. [Abstract] [Full Text] [PDF]

				S. Muto, T. Yoshii, K. Saito, Y. Kamiyama, H. Ide, and S. Horie Focal Therapy with High-intensity-focused Ultrasound in the Treatment of Localized Prostate Cancer Jpn. J. Clin. Oncol., March 1, 2008; 38(3): 192 - 199. [Abstract] [Full Text] [PDF]

				K. D. Evans, B. Weiss, and M. Knopp High-Intensity Focused Ultrasound (HIFU) for Specific Therapeutic Treatments: A Literature Review Journal of Diagnostic Medical Sonography, November 1, 2007; 23(6): 319 - 327. [Abstract] [PDF]

				J. Hindley, W. M. Gedroyc, L. Regan, E. Stewart, C. Tempany, K. Hynnen, N. Macdanold, Y. Inbar, Y. Itzchak, J. Rabinovici, et al. MRI Guidance of Focused Ultrasound Therapy of Uterine Fibroids: Early Results Am. J. Roentgenol., December 1, 2004; 183(6): 1713 - 1719. [Abstract] [Full Text] [PDF]

				J E Kennedy, G R ter Haar, and D Cranston High intensity focused ultrasound: surgery of the future? Br. J. Radiol., September 1, 2003; 76(909): 590 - 599. [Abstract] [Full Text] [PDF]

				C. M. C. Tempany, E. A. Stewart, N. McDannold, B. J. Quade, F. A. Jolesz, and K. Hynynen MR Imaging-guided Focused Ultrasound Surgery of Uterine Leiomyomas: A Feasibility Study Radiology, March 1, 2003; 226(3): 897 - 905. [Abstract] [Full Text] [PDF]

				K. Hynynen, O. Pomeroy, D. N. Smith, P. E. Huber, N. J. McDannold, J. Kettenbach, J. Baum, S. Singer, and F. A. Jolesz MR Imaging-guided Focused Ultrasound Surgery of Fibroadenomas in the Breast: A Feasibility Study Radiology, April 1, 2001; 219(1): 176 - 185. [Abstract] [Full Text]

				G J L H Van Leenders, H P Beerlage, E T. Ruijter, J J M C H de la Rosette, and C A van de Kaa Histopathological changes associated with high intensity focused ultrasound (HIFU) treatment for localised adenocarcinoma of the prostate J. Clin. Pathol., May 1, 2000; 53(5): 391 - 394. [Abstract] [Full Text] [PDF]